Treatment Patterns and Depression and Anxiety among Patients Newly Identified with Hyperhidrosis in a Real-World Database Representing US Commercial Health Plan Members

Main Article Content

M Hull
Optum Life Sciences, Minneapolis, MN

KK Gillard
Dermira, Inc., Menlo Park, CA

J Peterson-Brandt
Optum Life Sciences, Minneapolis, MN

SZ Klein
University of Utah Hospital, Salt Lake City, UT

Keywords

Hyperhidrosis, Depression, Anxiety

Abstract

Abstract not available.

References

1. Smith CC, Pariser D. Primary focal hyperhidrosis. Up-to-date 2018: https://www.uptodate.com/contents/primary-focal-hyperhidrosis?search=hyperhidrosis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1.
2. Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res 2016; 308(10):743-749.
3. Clinical Classification Software (CCS) for ICD-9-CM/ICD-10-CM. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp; www.hcup-us.ahrq.gov/toolssoftware/ccs10/ccs10.jsp
4. Bahar R, Zhou P, Liu Y, Huang Y, Phillips A, Lee TK, Su M, Yang S, Kalia S, Zhang X, Zhou Y. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2 016 D e c;75 (6):112 6 -1133.

Article Sidebar

Poster PDF
Published
Jan 28, 2020

Article Details

How to Cite
Hull, M., Gillard, K., Peterson-Brandt, J., & Klein, S. (2020). Treatment Patterns and Depression and Anxiety among Patients Newly Identified with Hyperhidrosis in a Real-World Database Representing US Commercial Health Plan Members. SKIN The Journal of Cutaneous Medicine, 4(1), S25. Retrieved from https://jofskin.org/33014/index.php/skin/article/view/805
Issue
Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
Section
Hyperhidrosis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.